Ribbon Acquisition Corp (RIBB)
Oxford Ledge is still expanding full research coverage of RIBB. A delayed quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A Cayman Islands acquisition company raised funds via IPO and is pursuing a merger with DRC Medicine.
Source: 10-K (2025-12-31) · AI-generated analysis. Not investment advice. May contain errors.
SEC filings
- 8-K Other material event 2026-06-10
- 8-K Other material event 2026-06-09
- 8-K Delisting / transfer of listing 2026-06-05
- 10-Q Quarterly financial report (unaudited) 2026-05-15
- 10-K/A Amended annual report 2026-04-24
Source: SEC EDGAR.
Annual results
1 year of annual figures for RIBB, as filed with the SEC. Figures are as reported and are not restated or adjusted.
| Fiscal year | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| 2025 | — | $690,218 | — |
Source: SEC EDGAR (XBRL company facts). Full statements and ratios in the terminal.
- Open RIBB in the Oxford Ledge terminal — delayed quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.